OvaScienceSM, (NASDAQ: OVAS), a life sciences company focused on the discovery, development and commercialization of new treatments for infertility, today announced that the Company's management team will present at two upcoming conferences in May. The conference and OvaScience presentation details ... read more

St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced CE Mark approval of its ILUMIEN™ OPTIS™ PCI Optimization System™, a new technology designed to provide physicians with a comprehensive disease assessment tool for treating patients with coronary artery disease (CAD). The system will ... read more

NCR Corporation (NYSE: NCR) will focus on ‘the life of a transaction’, for restaurants of all types and sizes at the upcoming National Restaurant Association (NRA) show in Chicago where the company will showcase the latest in restaurant technology innovation. Show attendees ... read more

Splunk Inc. (NASDAQ: SPLK), the leading software platform for real-time operational intelligence, today announced that Splunk® Enterprise is now available through trusted government IT solution provider Carahsoft Technology Corp.'s General Services Administration (GSA) Schedule, providing government ... read more

Gartner Application Architecture, Development & Integration Summit--Talend, a global open source software leader, today announced enhancements to the Talend Platform for Data Services that ensure that high quality and comprehensive data is always available to business applications and users in ... read more

Logicube® Inc., the industry’s leader in hard drive duplication and Digital Forensics technology, has announced the addition of the Forensic Falcon™ to its line of premier forensic imaging solutions. “Logicube’s Forensic Falcon™ will set a new standard in digital ... read more

ServiceNow® (NYSE: NOW), the enterprise IT cloud company, today announced data certification, a new capability in the ServiceNow CMDB (Configuration Management Database) that ensures data remains accurate, current and relevant. The CMDB typically serves as the single source of truth ... read more

Clovis Oncology (NASDAQ:CLVS) announced that three abstracts (ASCO Abstracts #2524, #2585, #2586) highlighting results from three Phase I studies of the company’s two lead compounds will be presented at the American Society of Clinical Oncology (ASCO) Annual Meeting 2013 in Chicago. ... read more

WebMediaBrands Inc. (Nasdaq: WEBM) today announced the addition of several new speakers to the 4th annual Inside Social Apps Conference & Expo, taking place June 6-7 in San Francisco. Conference sessions will tackle key issues and explore new opportunities facing ... read more

FeedHenry today announced that it will exhibit at Under the Radar 2013 next week in San Francisco, California. Under the Radar is Silicon Valley’s premiere startup showcase and will illuminate the latest innovation in business technology including the FeedHenry cloud-based Mobile Application Platform that enables enterprises ... read more

Transgenomic, Inc. (OTCBB: TBIO) today announced the global, commercial availability of CRC RAScan™, a new mutation detection test to screen patients with metastatic colorectal cancer (mCRC) for RAS mutations (KRAS and NRAS). These RAS mutations, identified using the CRC RAScan™ kits which use Surveyor®-Wave® ... read more

Marble Slab Creamery and MaggieMoo’s Ice Cream and Treatery found a way to differentiate against growing competition while increasing average transactions by more than 50 percent through MercuryLoyalty, a mobile and social based loyalty solution, integrated into the point of sale and offered through Mercury Payment ... read more

Kofax® plc (LSE: KFX), a leading provider of smart process applications for the business critical First Mile™ of customer interactions, today announced that Chief Executive Officer Reynolds C. Bish will present to investors at Craig-Hallum’s 10th Annual Institutional Investor Conference on May 29, 2013 at the ... read more

Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced that Phase 1 clinical data for IPI-145, its potent, oral inhibitor of phosphoinositide-3-kinase (PI3K)-delta and PI3K-gamma, will be presented at the 49th Annual Meeting of the American Society of Clinical Oncology (ASCO), which is being held from May 31 ... read more

Synta Pharmaceuticals Corp. (NASDAQ: SNTA) today announced scheduled presentations at the 2013 American Society for Clinical Oncology (ASCO) Annual Meeting, which is taking place May 31 – June 4 in Chicago. GALAXY-1 interim results ... read more

Gilead Sciences, Inc. (Nasdaq: GILD) today announced results from a Phase 2 study (Study 101-08) evaluating idelalisib (formerly GS-1101), an investigational, targeted, oral inhibitor of PI3K delta, in combination with rituximab for older patients with treatment-naïve chronic lymphocytic leukemia (CLL). This regimen achieved a complete ... read more

Bristol-Myers Squibb Company (NYSE:BMY) will host a teleconference at 7 p.m. EDT (6 p.m. CDT) on Sunday, June 2, 2013, to review data presented at the Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago. Company executives will provide an overview of data ... read more

FOSE 2013 has concluded the second day of its annual event, featuring a keynote presentation delivered by Federal CIO Steven VanRoekel. Throughout the day, technology professionals participated in keynotes, product demos and conference sessions focusing on five main tracks: Cloud and Virtualization; Cybersecurity; Mobile Government; Big ... read more

Today at Google I/O, Google’s annual developer conference, Google announced that in the coming months Android will include native support for Bluetooth Smart Ready and Bluetooth Smart devices. Phones and tablets with a dual-mode Bluetooth chip running the coming version ... read more

ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that clinical data on Iclusig® (ponatinib) and AP26113, its investigational inhibitor of anaplastic lymphoma kinase (ALK), epidermal growth factor receptor (EGFR) and c-ros oncogene (ROS1), will be presented at the Annual Meeting of ... read more